Apixaban + DAPT in Lowering Platelet Reactivity and Thrombin Generation

CompletedOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

July 10, 2018

Primary Completion Date

November 8, 2019

Study Completion Date

November 8, 2019

Conditions

Acute Coronary Syndrome

Interventions

DIAGNOSTIC_TEST

Flow Cytrometry; Thrombin Generation Assay

Apixaban combined with blood specimens (in vitro) of study participants

Trial Locations (1)

CirQuest Labs, LLC, Memphis

All Listed Sponsors

lead

CirQuest Labs, LLC

OTHER

NCT03746782 - Apixaban + DAPT in Lowering Platelet Reactivity and Thrombin Generation | Biotech Hunter | Biotech Hunter